A novel enzyme-linked immunosorbent assay specific for high-molecular- weight adiponectin

Journal of Lipid Research

Volumn 47, Issue 7, 2006, Pages 1572-1582

  Nakano, Yasuko ^a   Tajima, Sachiko ^a   Yoshimi, Ai ^a   Akiyama, Haruyo ^a   Tsushima, Motoo ^b,c   Tanioka, Toshihiro ^a   Negoro, Takaharu ^a   Tomita, Motowo ^a   Tobe, Takashi ^a  

^a SHOWA UNIVERSITY   (Japan)

^b INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^c KEIO UNIVERSITY   (Japan)

Author keywords

Gelatin binding protein of 28 kDa; High molecular weight multimer; Monoclonal antibody

Indexed keywords

ADIPONECTIN; GELATIN; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL FILTRATION CHROMATOGRAPHY; INTERMETHOD COMPARISON; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DENATURATION; WESTERN BLOTTING;

ADIPONECTIN; ADOLESCENT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, MONOCLONAL; CHO CELLS; CRICETINAE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MICE; MIDDLE AGED; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; MULTIPROTEIN COMPLEXES; PROTEIN STRUCTURE, QUATERNARY; RECOMBINANT PROTEINS;

EID: 33746087647     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.D600010-JLR200     Document Type: Article

References (33)

1. Maeda, K., K. Okubo, I. Shimomura, T. Funahashi, Y. Matsuzawa, and K. Matsubara. 1996. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochem. Biophys. Res. Commun. 221: 286-289.
2. Scherer, P. E., S. Williams, M. Fogliano, G. Baldini, and H. F. Lodish. 1995. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 10: 26746-26749.
3. Hu, E., P. Liang, and B. M. Spiegelman. 1996. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem. 271: 10697-10703.
4. Nakano, Y., T. Tobe, N. H. Choi-Miura, T. Mazda, and M. Tomita. 1996. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J. Biochem. (Tokyo). 120: 803-812.
5. Arita, Y., S. Kihara, N. Ouchi, M. Takahashi, K. Maeda, J. Miyagawa, K. Hotta, I. Shimomura, T. Nakamura, K. Miyaoka, et al. 1999. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257: 79-83.
6. Cnop, M., P. J. Havel, K. M. Utzschneider, D. B. Carr, M. K. Sinha, E. J. Boyko, B. M. Retzlaff, R. H. Knopp, J. D. Brunzell, and S. E. Kahn. 2003. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 46: 459-469.
7. Hotta, K., T. Funahashi, Y. Arita, M. Takahashi, M. Matsuda, Y. Okamoto, H. Iwahashi, H. Kuriyama, N. Ouchi, K. Maeda, et al. 2000. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 20: 1595-1599.
8. Statnick, M. A., L. S. Beavers, L. J. Conner, H. Corominola, D. Johnson, C. D. Hammond, R. Rafaeloff-Phail, T. Seng, T. M. Suter, J. P. Sluka, et al. 2000. Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int. J. Exp. Diabetes Res. 1: 81-88.
9. Nakamura, Y., K. Shimada, D. Fukuda, Y. Shimada, S. Ehara, M. Hirose, T. Kataoka, K. Kamimori, S. Shimodozono, Y. Kobayashi, et al. 2004. Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart. 90: 528-533.
10. Zoccali, C., F. Mallamaci, G. Tripepi, F. A. Benedetto, S. Cutrupi, S. Parlongo, L. S. Malatino, G. Bonanno, G. Seminara, F. Rapisarda, et al. 2002. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J. Am. Soc. Nephrol. 13: 134-141.
11. Tietge, U. J., K. H. Boker, M. P. Manns, and M. J. Bahr. 2004. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics. Am. J. Physiol. Endocrinol. Metab. 287: E82-E89.
12. Ouchi, N., S. Kihara, Y. Arita, K. Maeda, H. Kuriyama, Y. Okamoto, K. Hotta, M. Nishida, M. Takahashi, T. Nakamura, et al. 1999. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation. 100: 2473-2476.
13. Yokota, T., K. Oritani, I. Takahashi, J. Ishikawa, A. Matsuyama, N. Ouchi, S. Kihara, T. Funahashi, A. J. Tenner, Y. Tomiyama, et al. 2000. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood. 96: 1723-1732.
14. Ouchi, N., S. Kihara, Y. Arita, Y. Okamoto, K. Maeda, H. Kuriyama, K. Hotta, M. Nishida, M. Takahashi, M. Muraguchi, et al. 2000. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway. Circulation. 102: 1296-1301.
15. Ouchi, N., S. Kihara, Y. Arita, M. Nishida, A. Matsuyama, Y. Okamoto, M. Ishigami, H. Kuriyama, K. Kishida, H. Nishizawa, et al. 2001. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation. 103: 1057-1063.
16. Kubota, N., Y. Terauchi, T. Yamauchi, T. Kubota, M. Moroi, J. Matsui, K. Eto, T. Yamashita, J. Kamon, H. Satoh, et al. 2002. Disruption of adiponectin causes insulin resistance and neointimal formation. J. Biol. Chem. 277: 25863-25866.
17. Matsuda, M., I. Shimomura, M. Sata, Y. Arita, M. Nishida, N. Maeda, M. Kumada, Y. Okamoto, H. Nagaretani, H. Nishizawa, et al. 2002. Role of adiponectin in preventing vascular stenosis - the missing link of adipo-vascular axis. J. Biol. Chem. 277: 37487-37491.
18. Kobayashi, K., T. Inoguchi, N. Sonoda, N. Sekiguchi, and H. Nawata. 2005. Adiponectin inhibits the binding of low-density lipoprotein to biglycan, a vascular proteoglycan. Biochem. Biophys. Res. Commun. 335: 66-70.
19. Fruebis, J., T. S. Tsao, S. Javorschi, D. Ebbets-Reed, M. R. Erickson, F. T. Yen, B. E. Bihain, and H. F. Lodish. 2001. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. USA. 98: 2005-2010.
20. Yamauchi, T., J. Kamon, H. Waki, Y. Terauchi, N. Kubota, K. Hara, Y. Mori, T. Ide, K. Murakami, N. Tsuboyama-Kasaoka, et al. 2001. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7: 941-946.
21. Maeda, N., I. Shimomura, K. Kishida, H. Nishizawa, M. Matsuda, H. Nagaretani, N. Furuyama, H. Kondo, M. Takahashi, Y. Arita, et al. 2002. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 8: 731-737.
22. Yamauchi, T., J. Kamon, Y. Minokoshi, Y. Ito, H. Waki, S. Uchida, S. Yamashita, M. Noda, S. Kita, K. Ueki, et al. 2002. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8: 1288-1295.
23. Wang, Y., A. Xu, C. Knight, L. Y. Xu, and G. J. Cooper. 2002. Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. Potential role in the modulation of its insulin-sensitizing activity. J. Biol. Chem. 277: 19521-19529.
24. Tsao, T. S., H. E. Murrey, C. Hug, D. H. Lee, and H. F. Lodish. 2002. Oligomerization state-dependent activation of NF-κB signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30). J. Biol. Chem. 277: 29359-29362.
25. Pajvani, U. B., X. Du, T. P. Combs, A. H. Berg, M. W. Rajala, T. Schulthess, J. Engel, M. Brownlee, and P. E. Scherer. 2003. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J. Biol. Chem. 278: 9073-9085.
26. Tsao, T. S., E. Tomas, H. E. Murrey, C. Hug, D. H. Lee, N. B. Ruderman, J. E. Heuser, and H. F. Lodish. 2003. Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity: Different oligomers activate different signal transduction pathways. J. Biol. Chem. 278: 50810-50817.
27. Pajvani, U. B., M. Hawkins, T. P. Combs, M. W. Rajala, T. Doebber, J. P. Berger, J. A. Wagner, M. Wu, A. Knopps, A. H. Xiang, et al. 2004. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J. Biol. Chem. 279: 12152-12162.
28. Kobayashi, H., N. Ouchi, S. Kihara, K. Walsh, M. Kumada, Y. Abe, T. Funahashi, and Y. Matsuzawa. 2004. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ. Res. 94: e27-e31.
29. Yoda, M., Y. Nakano, T. Tobe, S. Shioda, N. H. Choi-Miura, and M. Tomita. 2001. Characterization of mouse GBP28 and its induction by exposure to cold. Int. J. Obes. Relat. Metab. Disord. 25: 75-83.
30. Nishizawa, H., I. Shimomura, K. Kishida, N. Maeda, H. Kuriyama, H. Nagaretani, M. Matsuda, H. Kondo, N. Furuyama, S. Kihara, et al. 2002. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes. 51: 2734-2741.
31. Xu, A., K. W. Chan, R. L.Hoo, Y.Wang, K. C. Tan, J. Zhang, B. Chen, M. C. Lam, C. Tse, G. J. Cooper, et al. 2005. Testosterone selectively reduces the high molecular weight formof adiponectin by inhibiting its secretion from adipocytes. J. Biol. Chem. 280: 18073-18080.
32. Maeda, N., M. Takahashi, T. Funahashi, S. Kihara, H. Nishizawa, K. Kishida, H. Nagaretani, M. Matsuda, R. Komuro, N. Ouchi, et al. 2001. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes. 50: 2094-2099.
33. Yang, W. S., W. J. Lee, T. Funahashi, S. Tanaka, Y. Matsuzawa, C. L. Chao, C. L. Chen, T. Y. Tai, and L. M. Chuang. 2001. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J. Clin. Endocrinol. Metab. 86: 3815-3819.